RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
UICGX
Price
$12.66
Change
-$0.57 (-4.31%)
Updated
Dec 18 closing price
Ad is loading...

RWIBX vs UICGX

Header iconRWIBX vs UICGX Comparison
Open Charts RWIBX vs UICGXBanner chart's image
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
Victory Capital Growth Institutional
Price$12.66
Change-$0.57 (-4.31%)
VolumeN/A
CapitalizationN/A
RWIBX vs UICGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWIBX vs. UICGX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Buy and UICGX is a Hold.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. UICGX (955M). RWIBX pays higher dividends than UICGX: RWIBX (1.05) vs UICGX (0.91). RWIBX was incepted earlier than UICGX: RWIBX (23 years) vs UICGX (9 years). UICGX is a more actively managed with annual turnover of: 41.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than UICGX: RWIBX (250) vs UICGX (1000000). RWIBX annual gain was more profitable for investors over the last year : 11.34 vs. UICGX (10.22). RWIBX return over 5 years is better than : 29.64 vs. UICGX (26.73).
RWIBXUICGXRWIBX / UICGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD9.7818.742112%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets121B955M12,670%
Annual Yield % from dividends1.050.91115%
Returns for 1 year11.3410.22111%
Returns for 3 years8.418.03105%
Returns for 5 years29.6426.73111%
Returns for 10 years44.22N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics